高级检索
当前位置: 首页 > 详情页

Detection of human papillomavirus genotypes associated with mucopurulent cervicitis and cervical cancer in Changchun, China

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]National Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China [2]Institute of Chinese Minority Traditional Medicine, Minzu University of China, Beijing, China [3]The First Hospital of Jilin University, Changchun, China [4]Department of Gynecologic Oncology, Sichuan Tumor Hospital, Chengdu, China [5]Department of Molecular Pharmacology, Sichuan Tumor Hospital, Chengdu, China
出处:
ISSN:

关键词: Cervical cancer Human papillomavirus Mucopurulent cervicitis Oncogenic genotype

摘要:
Objective: To determine the prevalence and genotype distribution of human papillomavirus (HPV) infection among Chinese patients with mucopurulent cervicitis (MPC) or cervical cancer (CC). Methods: In total, 191 cases of CC (n = 66), acute MPC (n = 84), and healthy cervix controls (n = 41) were initially included; samples were collected between May 21, 2008, and October 9, 2011. Cervical specimens were screened for HPV using a nested polymerase chain reaction assay and DNA sequencing. Results: Overall prevalence of HPV infection was 20.0% in the control group, 53.3% in the MPC group, and 93.8% in the CC group. The predominant genotype detected in all 3 groups was the oncogenic variant HPV 16 (87.7%, 18.7%, and 10.0% in the CC, MPC and control specimens, respectively). The second most frequent genotype among patients with MPC was HPV 58. This variant is also oncogenic and was detected at a higher rate in the MPC group (9.3%) than in the control (2.5%) and CC (1.5%) groups. Conclusion: Infection with HPV was prevalent among Chinese women with MPC or CC. Furthermore, the high prevalence of oncogenic genotypes observed among HPV-positive patients with MPC suggests that this group is at increased risk of developing CC. (c) 2012 Published by Elsevier Ireland Ltd. on behalf of International Federation of Gynecology and Obstetrics.

基金:

基金编号: 200504024 2006J 13-133 20674029

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 4 区 医学
小类 | 3 区 妇产科学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 妇产科学
JCR分区:
出版当年[2013]版:
Q3 OBSTETRICS & GYNECOLOGY
最新[2023]版:
Q2 OBSTETRICS & GYNECOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]National Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China
共同第一作者:
通讯作者:
通讯机构: [1]National Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China [*1]College of Life Science, Jilin University, 2699 Qianjin Street, Changchun 130012, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:54033 今日访问量:0 总访问量:4614 更新日期:2025-03-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号